Scopio Labs provides digital cell morphology imaging and AI solutions for hematology microscopy and diagnostics.
Scopio Labs has raised $42.0M in total funding. The most recent round was Series D. The last funding was announced in July 2024.
Scopio Labs's investors include Fortissimo Capital, OurCrowd, OTV, EASME, Mizrahi Tefahot Bank.
Scopio Labs is headquartered in Tel Aviv, Israel.
Scopio Labs provides digital cell morphology imaging and AI solutions for hematology microscopy and diagnostics.
Scopio Labs is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scopio Labs — Funding & Investors." VCBacked, July 25, 2024, https://www.vcbacked.co/company/scopio-labs. Accessed July 19, 2026.
VCBacked. (2024). Scopio Labs — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/scopio-labs
{{cite web |title=Scopio Labs — Funding & Investors |url=https://www.vcbacked.co/company/scopio-labs |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated